Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma

Journal of Hepatology 2026

View at publisher
Authors: Adam C. Yopp, M. C. Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Edward Cha, Stephen P. Hack, Qinshu Lian, Jessica Spahn, Chun Wu, Shukui Qin
+1 more Pierce Kah-Hoe Chow
DOI: 10.1016/j.jhep.2026.01.006
Cited by: 31
References: 27

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cholangiocarcinoma and Gallbladder Cancer Studies Liver physiology and pathology

Publication details

Journal / source
Journal of Hepatology
Publisher
Elsevier BV
Volume
84
Issue
6
Pages
1102–1111
Publication date
22 January 2026
Language
EN